For researchers, this translates to a compound that offers a sustained, powerful effect, but it also demands an unflinching respect for precise protocol
Incretin based therapies such as GLP-1 receptor agonists have revolutionised management of type 2 diabetes by enhancing insulin secretion, slowing gastric emptying and reducing appetite (Dungan & DeSantis, 2025)
Clinical trials show that patients who discontinue tirzepatide after initial weight loss regain approximately 14% of their body weight over 52 weeks
There is no data on retatrutide in people with a BMI below 27
Sermorelin is a synthetic form of growth hormone-releasing hormone (GHRH), used to raise levels of human growth hormone (hGH)
if you are taking other medicines (insulin, or a drug that stimulates insulin release), dose adjustments may be needed to reduce your risk of hypoglycemia